Clinical Trials Logo

Sedation clinical trials

View clinical trials related to Sedation.

Filter by:

NCT ID: NCT03996577 Recruiting - Sedation Clinical Trials

Intravenous Infusion of Lidocaine in ERCP

Start date: May 15, 2019
Phase: Phase 4
Study type: Interventional

Intravenous infusion of lidocaine significantly reduces propofol dose for ERCP and improve patients' recovery after ERCP.

NCT ID: NCT03983915 Not yet recruiting - Sedation Clinical Trials

Sedation Strategies for Therapeutic Bronchoscopy 2

Start date: June 17, 2019
Phase: N/A
Study type: Interventional

Therapeutic bronchoscopy is a common procedure to treat respiratory diseases. The procedure includes stent implantation, bronchus dilation, electronic incision, laser therapy, and so on. Most of these procedures are painful and require general anesthesia. Conventionally, the general anesthesia for therapeutic bronchoscopy was performed using laryngeal mask. But in the previous experiences, the investigators found that sedation with dexmedetomidine and remifentanil was as effect as laryngeal mask anesthesia. The present study was performed to compare the two approach for sedation or anesthesia in therapeutic bronchoscopy.

NCT ID: NCT03983889 Not yet recruiting - Sedation Clinical Trials

Sedation Strategies for Diagnostic Bronchoscopy 2

Start date: June 17, 2019
Phase: N/A
Study type: Interventional

Diagnostic bronchoscopy is an invasive procedure performed to diagnose respiratory diseases. But pain has been complained by most of the patients receiving such procedures. Sedation or anesthesia was required by both of the patients and bronchoscopists. Unfortunately, no consensus has been made upon the sedation strategies. Multiple sedation approaches have been applied, such as midazolam and fentanyl, remifentanil and propofol, dexmedetomidine and propofol. The present study was designed to compare these protocols in sedation for diagnostic bronchoscopy.

NCT ID: NCT03948880 Enrolling by invitation - Sedation Clinical Trials

Incidence OIRD Medical and Trauma Patients

Start date: July 29, 2019
Phase:
Study type: Observational

The primary objective of this prospective, blinded observational study is to correlate assessment of sedation and respiratory status with capnography and pulse oximetry monitoring in hospitalized adult medical and trauma patients receiving patient-controlled analgesia (PCA) or nurse administered intravenous opioids for acute pain. Nursing assessment of respiratory status and sedation level will be correlated with capnography and pulse oximetry values as technology-supported monitoring to identify respiratory depression and opioid-induced sedation. The secondary objective is to identify capnography and pulse oximetry values that correlate with respiratory decompensation and opioid-induced sedation in medical and trauma patients on the general care floor.

NCT ID: NCT03890094 Completed - Sedation Clinical Trials

Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study

Start date: January 1, 2018
Phase:
Study type: Observational

The aim of this study was to determine the safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation. A retrospective analysis was conducted on all patients undergoing bronchoscopy applying sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017.

NCT ID: NCT03844841 Completed - Atrial Fibrillation Clinical Trials

The Deep Sedation for Ablation Study

Start date: July 1, 2019
Phase: Phase 4
Study type: Interventional

Catheter ablation (CA) is an established therapeutic option for patients with symptomatic atrial fibrillation (AF). During the procedure, patients are usually sedated and analgesized, most commonly by administration of Propofol combined with opioids under the supervision of the electrophysiologist. However, due to the depressive effect of Propofol on the respiratory system, this regimen is not without risk. Dexmedetomidine is a highly selective alpha 2 agonist that demonstrates both analgesic and hypnotic properties with only weak effect on the respiratory system. The pharmacological profile of Dexmedetomidine may be advantageous for sedation during CA of AF. The aim of this randomized trial is to test this hypothesis and explore the safety and efficacy of Dexmedetomidine during CA of AF.

NCT ID: NCT03829293 Completed - Sedation Clinical Trials

High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation.

ODEPHI
Start date: March 26, 2019
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial comparing high-flow nasal oxygen therapy (HFNO) versus standard oxygen therapy (nasal prongs, nasopharyngeal catheter or standard face mask) during gastrointestinal (GI) endoscopy with sedation to reduce the incidence of hypoxia.

NCT ID: NCT03779061 Completed - Sedation Clinical Trials

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

Start date: June 28, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing colonoscopy.

NCT ID: NCT03775876 Completed - Sedation Clinical Trials

Dexmedetomidine Versus Propofol in Conjunction With Regional Block for Shoulder Arthroscopy

Start date: March 1, 2017
Phase: Phase 4
Study type: Interventional

Operative shoulder arthroscopy under regional block anesthesia often presents with hemodynamic challenges for the anesthesiologist, knowing that a low systolic blood pressure is required to minimize the bleeding. Regional anesthesia is successfully performed to many patients in whom tracheal intubation or the placement of a laryngeal tube is undesired. Propofol has traditionally been used to provide sedation in patients undergoing shoulder arthroscopy under regional anesthesia. In contrast to Propofol, Dexmedetomidine is a highly selective α-2 adrenoceptor agonist that has been shown to provide sedation, analgesia and anxiolytic effects with minimal respiratory depression. Due to the effect of both drugs on blood pressure, the investigators set out to compare intraoperative hemodynamics of both drugs, along with the surgeon's satisfaction and the degree of comfort provided to patients undergoing interscalene brachial plexus block for shoulder arthroscopy. The investigators also assessed whether the type of anesthetic agent used for sedation accounted for other differences in intra and post-operative outcome measures.

NCT ID: NCT03773874 Completed - Pain Clinical Trials

Assessment of Analgesia, Sedation, Physical Restraints and Delirium in Spanish Intensive Care Units

ASCyD
Start date: February 12, 2018
Phase:
Study type: Observational [Patient Registry]

This study assess which Spanish intensive care units evaluate and record, in a standardized way, levels of pain, sedation / agitation, use of physical restraints and prevalence of delirium. Also determine the use of validated assessment tools and explore levels of pain and sedation / agitation, use of physical restraints and prevalence of delirium.